Randomized controlled study between balloon and drill dilator as dilation device during EUS-guided hepaticogastrostomy
Not Applicable
- Conditions
- Biliary obstruction
- Registration Number
- JPRN-UMIN000049539
- Lead Sponsor
- Osaka Medical and Pharmaceutical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with total gastorectomy 2. ascites between hepatic parenchyma and stomach wall 3. Pregnancy, easy bleeding 4. Patient refusal to attend the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Technical success rate of dilation device insertion
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of balloon versus drill dilators in EUS-guided hepaticogastrostomy for biliary obstruction?
How does the effectiveness of balloon and drill dilators compare to standard-of-care treatments for biliary obstruction in patients with pancreatic cancer?
What biomarkers are associated with successful dilation outcomes in EUS-guided hepaticogastrostomy for malignant biliary obstruction?
What are the potential adverse events and management strategies for balloon and drill dilators during EUS-guided hepaticogastrostomy?
Are there any combination approaches or alternative therapies being explored alongside EUS-guided hepaticogastrostomy for biliary obstruction in Japan?